Christopher Boone, global head of health economics and outcomes research at AbbVie, advises ... to get to state where there is more widespread application of them, a more systematic approach ...

The death took place recently in Chicago, USA of Julie Corduff. The deceased was the daughter of Kate and Peter Sheridan RIP, ...

casting doubt on the future of the scheme in its present form. AbbVie and Eli Lilly have left the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), according to an update issued ...

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options ...

So far, five biosimilars that reference Eylea 2 mg have been approved by the FDA. Alvotech/Teva expect to regulatory approval ...

Alvotech and Teva Pharmaceuticals announced the US Food and Drug Administration (FDA) has accepted for review a Biologics ...

CVs and/or application requests sent via email will not be answered ... Occasionally, some roles may still require candidates to apply by completing a Personal History Form (PHF) word document and ...

Injectable Drug Delivery MarketThe global injectable drug delivery market is estimated to be valued at USD 49.44 billion in 2024, with strong growth expectations due to advancements in healthcare, ...

In addition to the top 100 Best Workplaces for Innovators, our seventh annual list will recognize outstanding companies in a ...